Timothy Schmid is EVP, WW Chair, MedTech of JOHNSON & JOHNSON. Currently has a direct ownership of 13,040 shares of JNJ, which is worth approximately $2.09 Million. The most recent transaction as insider was on Feb 13, 2024, when has been sold 250 shares (Common Stock) at a price of $157.85 per share, resulting in proceeds of $39,462. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13K
0% 3M change
n/a 12M change
Total Value Held $2.09 Million

Timothy Schmid Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2024
SELL
Payment of exercise price or tax liability
$39,462 $157.85 p/Share
250 Reduced 1.88%
13,040 Common Stock
Feb 13 2024
BUY
Exercise of conversion of derivative security
-
499 Added 3.62%
13,290 Common Stock
Feb 12 2024
SELL
Payment of exercise price or tax liability
$454,413 $157.4 p/Share
2,887 Reduced 18.41%
12,791 Common Stock
Feb 12 2024
BUY
Exercise of conversion of derivative security
-
5,736 Added 26.79%
15,678 Common Stock
Feb 08 2024
SELL
Payment of exercise price or tax liability
$156,486 $156.33 p/Share
1,001 Reduced 9.15%
9,942 Common Stock
Feb 08 2024
BUY
Exercise of conversion of derivative security
-
1,964 Added 15.22%
10,943 Common Stock
TS

Timothy Schmid

EVP, WW Chair, MedTech
New Brunswick, NJ

Track Institutional and Insider Activities on JNJ

Follow JOHNSON & JOHNSON and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

News

Receive news related to JOHNSON & JOHNSON

Track Activities on JNJ